Work

Effect of MUC16 mutations on tumor mutation burden and its potential prognostic significance for cutaneous melanoma.

Year: 2022
Type: article
Abstract: OBJECTIVES: , a mucin marker with a high mutation probability, is closely related to the occurrence, development, response to treatment, and prognosis of melanoma. As melanoma has high immunogenicity, immunotherapy has become a routine treatment. Tumor mutation burden (TMB) is the most common indicator for determining appropriate immunotherapy. The relationship between the mutation and expression of MUC16 and the prognosis, TMB, level of immune infiltration, and drug sensitivity in melanoma was investigated in this study. METHODS: expression and drug sensitivity was also discussed. RESULTS: expression may be related to abnormal methylation and drug resistance. CONCLUSION: may affect immune-related pathways and tumor-infiltrating immune cell subsets, which may improve the prognosis for melanoma patients.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W4226330203
FWCI: 1.506
Cites: 51
Cited by: 18
Related to: 10